---
title: Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis
  of hepatocellular carcinoma
date: '2023-11-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37920152/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231104180909&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: We identified a panel of Hp glycopeptides that are significantly
  differentially regulated in early- and late-stage HCC. Some glycobiomarkers exceeded
  the diagnostic value of AFP (the most commonly used biomarker for HCC diagnosis).
  Our findings provide evidence that glycobiomarkers can be effective in the diagnosis
  of early HCC - individually, as a panel of glycopeptides or combined with conventional
  serological ...'
disable_comments: true
---
CONCLUSION: We identified a panel of Hp glycopeptides that are significantly differentially regulated in early- and late-stage HCC. Some glycobiomarkers exceeded the diagnostic value of AFP (the most commonly used biomarker for HCC diagnosis). Our findings provide evidence that glycobiomarkers can be effective in the diagnosis of early HCC - individually, as a panel of glycopeptides or combined with conventional serological ...